Redmile Group, LLC Silence Therapeutics PLC Transaction History
Redmile Group, LLC
- $822 Million
- Q2 2025
A detailed history of Redmile Group, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Redmile Group, LLC holds 2,164,777 shares of SLN stock, worth $15.5 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
2,164,777
Previous 2,214,947
2.27%
Holding current value
$15.5 Million
Previous $6.25 Million
101.01%
% of portfolio
1.53%
Previous 0.66%
Shares
6 transactions
Others Institutions Holding SLN
# of Institutions
57Shares Held
20.6MCall Options Held
22.8KPut Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$21.8 Million3.59% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$20.9 Million0.87% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$13.3 Million0.9% of portfolio
-
Morgan Stanley New York, NY1.21MShares$8.69 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.11MShares$7.93 Million1.36% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $257M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...